AKT1 and COVID-19: A network pharmacology analysis suggested that Lianhua Qingwen capsules might potentially treat and prevent COVID-19 by targeting the serine/threonine protein kinase (Akt1) [26], which is involved in viral infection, lung injury, and lung fibrosis [27].